✦ LIBER ✦

Urinary hydroxyproline excretion in early and advanced breast cancer–a sequential study

✍ Scribed by A. Cuschieri

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 388 KB
Volume: 60
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800601012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early morning hydroxyproline excretion i

Early morning hydroxyproline excretion in patients with breast cancer

✍ T. J. Powles; Geraldine Rosset; C. L. Leese; P. K. Bondy 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Urinary hydroxyproline and prognosis in

Urinary hydroxyproline and prognosis in human breast cancer

✍ C. S. Grant; S. A. Hoare; R. R. Millis; J. L. Hayward; D. Y. Wang 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

A phase II study of peptichemio in advan

A phase II study of peptichemio in advanced breast cancer

✍ V. Hug; G. N. Hortobagyi; A. U. Buzdar; G. R. Blumenschein; W. Grose; M. A. Burg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

Adriamycin combinations in advanced brea

Adriamycin combinations in advanced breast cancer: A southwest oncology group study

✍ B. L. Tranum; B. McDonald; T. Thigpen; C. Vaughn; H. Wilson; T. Maloney; J. Cost 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 2 views

Sequential bone scans and chest radiogra

Sequential bone scans and chest radiographs in the postoperative management of early breast cancer

✍ M. A. Chaudary; M. N. Maisey; P. J. Shaw; R. D. Rubens; J. L. Hayward 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

A phase II study of combined 5-fluoroura

A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer

✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; Göran Bjelkengren 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c